Corbus Pharma (CRBP) Reports Q4 Loss of $0.28/Share

Corbus Pharma (NASDAQ: CRBP) reported Q4 EPS of ($0.28), versus ($0.13) reported last year. Revenue for the quarter came in at $648.4 thousand, versus $0 reported last year.

For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Bernstein SocGen on Darden Restaurants (DRI): 'Story Intact'
• Benchmark Reiterates Buy Rating on IMAX Corporation (IMAX), Highlights 'The Odyssey' Potential